Dr. Dyanesh Bapu G. Ravindran, MD

Dr. Ravindran practices at Solano Hematology - Oncology in Vallejo, California.

Dr. Ravindran's NPI, 1659387132, was assigned on August 1, 2006. Dr. Ravindran graduated from All India Institute of Medical Sciences in 1990. Dr. Ravindran holds Texas license K4204.

Dr. Ravindran's primary practice is Solano Hematology - Oncology, at 100 Hospital Dr, Vallejo, CA 94589 in Solano County. The practice phone is (707) 551-3300.

Dr. Ravindran's primary practice is Solano Hematology - Oncology in Vallejo, California. Dr. Ravindran is also affiliated with Sutter Solano Medical Center. The medical group on file is Solano Hematology Oncology. Dmand AI also links Dr. Ravindran to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ravindran practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ravindran's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ravindran is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ravindran's licenses on file in 4 states: Texas, California, Colorado and Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Ravindran treats.

CMS data shows 85,349 Medicare services from Dr. Ravindran across 54 procedure codes in 2024, for 241 Medicare patients. Medicare paid $1,205,321 for them.

CMS counts 241 Medicare patients who saw Dr. Ravindran in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 73% have chronic kidney disease. 61% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ravindran's median patient age at 68, with 60% women.

In 2024, Dr. Ravindran wrote 436 Medicare Part D claims for 109 patients. 77% of them were for generic drugs. CMS names the drug for 196 of them, across 12 drugs with 11 or more claims each, at $15,297 in total drug cost. In 2023, CMS named 603 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ravindran for performance year 2024, reported as part of a group. Dr. Ravindran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 601 general payments to Dr. Ravindran from 69 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Heron Therapeutics, Inc. paid the most, $2,541.

Dmand AI lists 1 award for Dr. Ravindran, most recently CMS Stage 1 EHR in 2011.

Dr. Ravindran graduated from All India Institute of Medical Sciences in 1990.

Dr. Ravindran is in network with 16 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.